Published Studies Related to Furosemide Injection
Well-designed clinical trials related to Furosemide Injection
Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: A double blind randomized controlled trial. [2009.12.26]
Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. [2009.10]
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. [2009.08]
Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. [2009.07.01]
Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. [2009.02]
Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. [2008.10]
Furosemide inhalation in dyspnea of mustard gas-exposed patients: a triple-blind randomized study. [2008.07]
Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. [2008.07]
Impact of intravenous furosemide on flow rate characteristics and clinic waiting times. [2008.04]
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. [2008.02]
Inhaled furosemide does not alleviate respiratory effort during flow-limited exercise in healthy subjects. [2008]
Effect of inhaled furosemide on air hunger induced in healthy humans. [2007.04.16]
NXY-059 does not significantly interact with furosemide in healthy volunteers. [2006.12]
The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. [2006.11.29]
Topical furosemide versus oral steroid in preoperative management of nasal polyposis. [2006.08]
Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma. [2006.03]
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure. [2006]
Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study. [2004.04]
Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. [2003.09]
[Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure] [2000.08]
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. [1998.02.07]
Comparison of 6-hour infusion versus bolus furosemide in premature infants. [1998.01]
Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. [1998]
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. [1997.07]
Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. [1997.06]
Variable furosemide absorption and poor predictability of response in elderly patients. [1997.01]
Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. [1996.08]
Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. [1994.11.24]
Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. [1994.03]
Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure. [1994.02]
Effects of imidazole-salicylate on renal function and the diuretic action of furosemide in cirrhotic patients with ascites. [1993.09]
Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection. [1993.08]
Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. [1992.09]
Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. [1992.04]
Potential deleterious effect of furosemide in radiocontrast nephropathy. [1992]
Furosemide absorption in patients with cirrhosis. [1991.03]
Well-designed clinical trials possibly related to Furosemide Injection
Blood pressure lowering efficacy of loop diuretics for primary hypertension. [2009.10.07]
Compression garments as countermeasures to orthostatic intolerance. [2009.05]
Hyper osmolality does not modulate natriuretic peptide concentration in patients after coronary artery surgery. [2009.05]
Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. [2009.04]
Variability of aortic blood flow predicts fluid responsiveness in spontaneously breathing healthy volunteers. [2009.03]
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. [2009.02]
Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. [2009.01.01]
Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion. [2008.12]
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? [2008.02]
Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. [2007.11.06]
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. [2007.11]
Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. [2007.10]
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs. [2007.09]
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. [2007.08.28]
Fenoldopam and gastric tonometry during orthotopic liver transplantation. [2007.07]
Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. [2007.04.24]
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. [2007.03.28]
Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling. [2007.03]
Frusemide administration in critically ill patients by continuous compared to bolus therapy. [2007]
Effect of various diuretic treatments on rosiglitazone-induced fluid retention. [2006.12]
Intravenous frusemide for transient tachypnoea of the newborn: a randomised controlled trial. [2006.10]
Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study. [2006.10]
Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. [2006.10]
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. [2006.10]
Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study. [2006.09.15]
Is improved high speed performance following frusemide administration due to diuresis-induced weight loss or reduced severity of exercise-induced pulmonary haemorrhage? [2006.08]
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. [2006.08]
Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. [2006.07]
Comparison of two fluid-management strategies in acute lung injury. [2006.06.15]
Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor. [2006.05]
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. [2006.04]
A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170]. [2006.03.13]
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. [2006.02]
Single dose parecoxib significantly improves ventilatory function in early extubation coronary artery bypass surgery: a prospective randomized double blind placebo controlled trial. [2006.02]
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. [2006.02]
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans? [2003.10]
A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. [2003.08]
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. [2003.01.15]
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. [2001.06.01]
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. [2000.09]
A prospective randomized trial comparing 2 diuresis renography techniques for evaluation of suspected upper urinary tract obstruction in children. [1998.05]
Pulmonary vascular pressures of strenuously exercising Thoroughbred horses after administration of phenylbutazone and frusemide. [1998.03]
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide. [1998.01]
Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants. [1997.07]
Natriuretic efficiency of frusemide as a consequence of drug input rate. [1997.05]
[Analysis of the curative effect on ascites in liver cirrhosis by integrated traditional Chinese and Western medicine] [1997]
Effects of hypovolemia and posture on responses to the Valsalva maneuver. [1996.04]
The renin angiotensin aldosterone system and frusemide response in congestive heart failure. [1995.01]
Dose-response study of intravenous torsemide in congestive heart failure. [1994.08]
The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency. [1994.07]
The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency. [1994.07]
Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in man. [1994.04]
Abnormal glomerular and tubular response to intravenous frusemide in patients with chronic glomerulonephritis. [1991]
[Intravenous enoximone versus conventional treatment in acute lung edema. Preliminary results of a randomized study] [1990.09]
Acute pulmonary oedema: preliminary results of a randomized trial of the intravenous phosphodiesterase inhibitor, enoximone, vs conventional therapy. [1990.07]
The effects of cilazapril alone and in combination with frusemide in healthy subjects. [1989]
Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin. [1988.05]
Other research related to Furosemide Injection
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. [2009.06]
Effect of furosemide on radioiodine-131 retention in mice thyroid gland. [2009.05]
A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience. [2009.05]
Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. [2009.01]
Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs. [2008.12]
High-Dose Furosemide and Small-Volume Hypertonic Saline Solution Infusion for the Treatment of Leg Edema in Advanced Cancer Patients. [2008.09.12]
Narrative review: furosemide for hypercalcemia: an unproven yet common practice. [2008.08.19]
Ethnic differences in renal responses to furosemide. [2008.08]
|
